NAV
$32.95
AUM
$55.4M
Expense Ratio
-
Dividend Yield
0.00%
Beta
0.68
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +20.01% | +0.91% | +14.39% | +15.69% | +19.28% | +5.20% |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | TSTXX | BlackRock Liquidity T-Fund Instl | 10.90% |
| 2 | SNOW | Snowflake Inc Ordinary Shares | 3.03% |
| 3 | MU | Micron Technology Inc | 2.77% |
| 4 | K.TO | Kinross Gold Corp | 2.63% |
| 5 | CLS.TO | Celestica Inc Ordinary Shares (Subordinate Voting) | 2.60% |
| 6 | KRYS | Krystal Biotech Inc | 2.56% |
| 7 | SCI | Service Corp International | 2.53% |
| 8 | OSCR | Oscar Health Inc Class A | 2.52% |
| 9 | LRCX | Lam Research Corp | 2.50% |
| 10 | UNH | UnitedHealth Group Inc | 2.50% |
The fund is an actively managed ETF that seeks to achieve its investment objective by purchasing securities the Adviser, believes have above-average financial characteristics such as return on invested capital, profit margins, debt-to-equity ratio, or revenue and earnings growth as identified in financial statements, relative to the broader equity market; are undervalued based on valuation metrics such as (i) enterprise value to sales, (ii) enterprise value to earnings before interest, taxes, depreciation, and amortization, or (iii) price to earnings ratios.
Inception Date: 2020-11-12